Catalyst Wire Dossier Catalyst Wire Dossier

HDV-Interferon

· Hepasome Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HDV-Interferon, covering 2009-01-09 to 2009-01-09. Get the full timeline:

Most recent: Clinical Trial Update: HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients [Phase 2]

See pricing